Track the Eastwood Bio-Medical Canada Inc. stock price and the full insider trade history of the company, a listed equity based in Canada. Shares trade on CA CA, under the supervision of SEDI. Market capitalisation: €66.8m. The latest transaction was reported on 4 August 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Eastwood Bio-Medical Research Inc.. The full history is openly available.
Eastwood Bio-Medical Canada Inc. reported a total of 90 insider trading declarations in the last 90 days, with total purchases amounting to 111,178 EUR and no sales. The top insiders include Eastwood Bio-Medical Research Inc., a 3-10% security holder, with 52 declarations totaling approximately 84,644.51 EUR, and Kim, Yunji, a senior officer, with 34 declarations totaling about 21,968.40 EUR. Other notable insiders include Cranewood Financial Corporation, also a 3-10% security holder, with 4 declarations totaling approximately 4,564.92 EUR. Recent significant purchases include multiple transactions by Eastwood Bio-Medical Research Inc. on July 8, July 21, and July 10, 2026, with amounts ranging from approximately 5,497.34 EUR to 7,174.90 EUR. Kim, Yunji also made purchases on June 25, 2026, totaling approximately 4,242.91 EUR and 3,414.67 EUR.
Auto-generated summary, refreshed daily.Updated 2d ago
90
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
39Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,192 of 28,065 companies
39.6
score / 100
Value
34
Quality
45
FCF yld0.0%
Earn yld-0.5%
EV/EBITDA·
ROE·
Gross mgn70%
Net mgn-43%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
500 shares@ CA$0.980.0007% mcap1.8% of flowCommon SharesTSXSEDI:4751252
Canonical exit: 7 Oct 2026 (T+90)
25 of 90 declarations
About Eastwood Bio-Medical Canada Inc.
Eastwood Bio-Medical Canada Inc. is a company focused on the biomedical sector, providing innovative solutions for the Canadian market. It is listed on the Toronto Stock Exchange (XTSE).